SPS 2018: Implementing Human iPSC-derived Cells in Early Safety Assessment & Disease Modeling

SPS 2018: Implementing Human iPSC-derived Cells in Early Safety Assessment & Disease ModelingПодробнее

SPS 2018: Implementing Human iPSC-derived Cells in Early Safety Assessment & Disease Modeling

Probing disease mechanisms in ALS using iPSCs, reprogramming and optogenetic approachesПодробнее

Probing disease mechanisms in ALS using iPSCs, reprogramming and optogenetic approaches

Human iPSC-based disease modeling and therapeutic developmentПодробнее

Human iPSC-based disease modeling and therapeutic development

Human iPSC-derived Midbrain Dopaminergic Neurons for Parkinson’s Disease Modeling and Cell TherapyПодробнее

Human iPSC-derived Midbrain Dopaminergic Neurons for Parkinson’s Disease Modeling and Cell Therapy

Exploring the Role of iPSC-cardiomyocytes in Drug Discovery and Safety AssessmentПодробнее

Exploring the Role of iPSC-cardiomyocytes in Drug Discovery and Safety Assessment

Tools & Strategies for Implementing iPSC-based Cell Models for Neurodegenerative Disease Drug Dis...Подробнее

Tools & Strategies for Implementing iPSC-based Cell Models for Neurodegenerative Disease Drug Dis...

Using Patient Specific iPSC-Cardiomyocytes for Disease ModelingПодробнее

Using Patient Specific iPSC-Cardiomyocytes for Disease Modeling

Utilizing Stem Cell-derived Cardiomyocytes for Early Safety Screening - Webinar PresentationПодробнее

Utilizing Stem Cell-derived Cardiomyocytes for Early Safety Screening - Webinar Presentation

Using Human iPSC-derived Cell-Types in Novel Functional Assays, Disease Modeling and Drug DiscoveryПодробнее

Using Human iPSC-derived Cell-Types in Novel Functional Assays, Disease Modeling and Drug Discovery

Advances in Modeling Human Diseases Using Induced Pluripotent Stem Cell-derived Cellular ModelsПодробнее

Advances in Modeling Human Diseases Using Induced Pluripotent Stem Cell-derived Cellular Models

Addressing the scalability of human iPSC-derived neurons for HTS implementationПодробнее

Addressing the scalability of human iPSC-derived neurons for HTS implementation

Modeling Lipid and Glucose Metabolism Using Human iPSC-derived HepatocytesПодробнее

Modeling Lipid and Glucose Metabolism Using Human iPSC-derived Hepatocytes

Modeling Lipid and Glucose Metabolism Using Human iPSC-derived HepatocytesПодробнее

Modeling Lipid and Glucose Metabolism Using Human iPSC-derived Hepatocytes

High-Throughput Assessment of Compound-Induced Cardiotoxicity Using Human iPSC-Derived CardiomyocyteПодробнее

High-Throughput Assessment of Compound-Induced Cardiotoxicity Using Human iPSC-Derived Cardiomyocyte

Refining Toxicity Testing through Advances in Human iPSC TechnologyПодробнее

Refining Toxicity Testing through Advances in Human iPSC Technology

Diabetic Cardiomyopathy Modeling & Screening with iPSC CardiomyocytesПодробнее

Diabetic Cardiomyopathy Modeling & Screening with iPSC Cardiomyocytes

Using iPS cell technology to model human neurodegenerative diseasesПодробнее

Using iPS cell technology to model human neurodegenerative diseases

IPSC-Derived Human Neurons: Introduction and ApplicationПодробнее

IPSC-Derived Human Neurons: Introduction and Application

Improvements in building in vitro pluripotent stem cell-derived disease modelsПодробнее

Improvements in building in vitro pluripotent stem cell-derived disease models

Modeling Barth syndrome using patient-specific, iPSC-derived cardiomyocytesПодробнее

Modeling Barth syndrome using patient-specific, iPSC-derived cardiomyocytes